Your browser doesn't support javascript.
loading
Immunogenic PANoptosis-Initiated Cancer Sono-Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle.
Zhou, Liqiang; Lyu, Jinxiao; Liu, Fang; Su, Yanhong; Feng, Ling; Zhang, Xuanjun.
Afiliação
  • Zhou L; Faculty of Health Sciences, University of Macau, Macau SAR, 999078, P. R. China.
  • Lyu J; MOE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, 999078, P. R. China.
  • Liu F; Faculty of Health Sciences, University of Macau, Macau SAR, 999078, P. R. China.
  • Su Y; Faculty of Health Sciences, University of Macau, Macau SAR, 999078, P. R. China.
  • Feng L; Faculty of Health Sciences, University of Macau, Macau SAR, 999078, P. R. China.
  • Zhang X; Faculty of Health Sciences, University of Macau, Macau SAR, 999078, P. R. China.
Adv Mater ; 36(2): e2305361, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37699593
The cancer-immune cycle conceptualized the mechanisms of driving T cell responses to tumors, but w as limited by immunological ignorance elicited by tumor inherent immunoediting, which failed to initiate and maintain adaptive immunity. Targeting specific vulnerabilities of cell death patterns may provide unique opportunities to boost T cell antitumor immunological effects. Here an ultrasound nanomedicine-triggered tumor immuno-reediting therapeutic strategy using nano/genetically engineered extracellular vesicles, which can induce tumor highly immunogenic PANoptosis and iteratively start-up the energization of cancer innate immunity cycle by repeatedly liberating damage-associated molecular patterns, thereby priming sufficient antigen-specific T cells and shaping protective immune response through activating cGAS-STING signaling pathways, is reported. Aided by immune checkpoint blockade, the reprogramming of immune microenvironment further facilitated a prompt bridging of innate and adaptive immunity, and remarkably suppressed metastatic and rechallenged tumor growth. Thus, targeting PANoptotic cell death provides a catcher against immune escape and a positive-feedback immune activation gateway for overcoming immune resistance to intractable cancers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article